SCHEMBL18172214

SCHEMBL18172214

Cc1nc(-c2ccccc2-n2ncc(C(=O)Nc3ccc(C(F)(F)F)cn3)c2N)no1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 11/20 0.66
SCN5A Q14524 3/20 0.49
GAA P10253 1/20 0.45
PTGS1 P23219 2/20 0.45
LCK P06239 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPK14 Q16539 1/20 0.43
HCRTR1 O43613 1/20 0.41
F10 P00742 1/20 0.41
PTGES O14684 1/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
FGFR4 P22455 1/20 0.40
MAPKAPK2 P49137 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18172171 0.80 SCN9A (0.78) SCN9ASCN5AGAAPTGS1F10
SCHEMBL18172119 0.80 SCN9A (1.00) SCN9ASCN5AGAAPTGS1F10
SCHEMBL18172231 0.80 SCN9A (0.75) SCN9ASCN5AGAAPTGS1HCRTR1
SCHEMBL18172107 0.79 SCN9A (0.80) SCN9ASCN5AGAAPTGS1HCRTR1
SCHEMBL18172191 0.79 SCN9A (0.75) SCN9ASCN5AGAAPTGS1HCRTR1
SCHEMBL18172174 0.79 SCN9A (0.75) SCN9ASCN5AGAAPTGS1LCK
SCHEMBL18172216 0.79 SCN9A (0.72) SCN9ASCN5AGAAPTGS1LCK
SCHEMBL18172037 0.77 SCN9A (0.75) SCN9ASCN5AGAAPTGS1MAPK14
SCHEMBL18172237 0.77 SCN9A (0.72) SCN9ASCN5AGAAPTGS1MAPK14
SCHEMBL18172229 0.76 SCN9A (0.68) SCN9ASCN5AGAAPTGS1HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3286178-A1 AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS Almirall S.A. (ES) 2018-02-28 EP disclosed
WO-2016170009-A1 AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS ALMIRALL, S.A. (ES) 2016-10-27 WO disclosed